Date: 09 February 2017
Coming on the back of the news today reported by the National Institute for Health Research (NIHR) that over one million people in primary care have actively participated in research studies. GP practices in Greater Manchester have got a research study off to a flying start with record numbers being recruited by the NIHR CRN Greater Manchester Primary Care team in an incredibly short time to a potential life saving device.
Currently the 12 lead ECG (Electrocardiogram Test) device is the standard for the diagnosis of the disease, but with cutting edge technology the study hopes to reform the process with the introduction of a novel handset that will revolutionise the way to perform an ECG. The Rapid Rhythm portable handset enables GP's and consultants to help detect irregular and abnormally fast heart rates in patients through a simple on the spot test.
The study which is being run by the Centre for Primary Care at The University of Manchester in association with Trustech, aims to compare existing practices to the Rapid Rhythm Handset.
Patients with Atrial Fibrillation (a heart condition that causes an irregular and often abnormally fast heart rate) have a much higher chance of developing other problems such as Stroke and many patients could benefit if screening was made quicker and easier and this is where Rapid Rhythm comes in.
The CRN Primary Care Team recruited an astonishing 1033 patients to the study in just 3 months. Special praise was given to Bridge House Medical Centre for recruiting 100 patients in a matter of weeks and Bollington Medical Centre who recruited 122 patients.
78 year old Janet Mason took part in the study at her local Doctors surgery, Bollington Medical Centre, “It was really easy, the nurse explained what would happen clearly, it didn’t take long to put the device on and it wasn’t at all uncomfortable, the whole process took 20 minutes. I know how important research is and I’m glad that I could help”
67 year old David Rance took part in the study at his local surgery, Bridge House Medical Centre, “I was happy to take part, I didn’t find it invasive. It actually benefited me because it identified an irregular heartbeat so now my medication has changed. Taking part in research not only helped others, it helped me”
Julie Melville, Divisional Lead Research Nurse who worked on the study said
“We had an excellent response from patients, they were very keen to support the Rapid Rhythm study and had the added benefit of a mini health screen. The success of Rapid Rhythm is due to the collaboration and team work of everyone involved. Research such as this is so important, it is through research that we are able to treat, and eventually cure conditions affecting the lives of millions of people”
Rapid Rhythm Ltd is a spin-out company from Central Manchester University Hospitals NHS Foundation Trust (CMFT). The product, also called Rapid Rhythm, originates from inventor and Consultant Cardiologist, Dr Adam Fitzpatrick.
You may also be interested in